Cost-effectiveness analysis of colorectal cancer treatments

Eur J Cancer. 2002 May;38(7):953-63. doi: 10.1016/s0959-8049(02)00053-9.


A concise overview is provided of the methodology of cost-effectiveness analyses, followed by a survey of published CEAs of colorectal cancer treatments. To gain credibility, the methodology applied in CEAs must be further improved. Costs are rarely estimated from the societal perspective, and little is known about how colorectal patients value their treatment and health.

Publication types

  • Review

MeSH terms

  • Chemotherapy, Adjuvant / economics
  • Colorectal Neoplasms / economics*
  • Colorectal Neoplasms / therapy
  • Cost-Benefit Analysis
  • Follow-Up Studies
  • Health Care Costs
  • Humans
  • Quality-Adjusted Life Years